OHSU in the news

Cytokinetics Presents New Data in Patients With Non-Obstructive HCM From Cohort 4 of REDWOOD-HCM in Late-Breaking Clinical Trial Session at The European Society of Cardiology Heart Failure 2023 Congress

Cytokinetics May 20, 2023
Ahmad Masri, M.D., presented new findings from a Phase 2 clinical trial of the drug aficamten as a possible treatment for non-obstructive hypertrophic cardiomyopathy, including data that indicates trial participants experienced a “statistically significant improvement” in reported health status.

State of Cancer Research: Impact of COVID-19, Brexit, War, and Other Global Events

Cancer Therapy Advisor May 19, 2023
In a Cancer Therapy Advisor article on the state of cancer research, Lisa Coussens, Ph.D., discusses some of the struggles the field has faced since the COVID-19 pandemic. She says: “A lot of young people left the field. Some postdocs decided to abandon an academic postdoc during the pandemic because if they were here on a visa with a limited amount of funding to support their career in the US and the lab was going to be closed for 6 to 9 months, they went home.”
See more stories